A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT06381141 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06381141
- Sponsor
- Cullinan Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-03
- Primary completion
- 2026-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.